Related Experiment Videos
Genetic basis of primary hyperoxaluria type II
1Department of Urology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.
Molecular Urology
|January 13, 2001
Summary
Primary hyperoxaluria Type II (PH2) is a rare genetic disorder causing high oxalate and L-glycerate in urine. Understanding the GRHPR enzyme
Area of Science:
- Biochemistry
- Genetics
- Nephrology
Background:
- Primary hyperoxaluria Type II (PH2) is a rare genetic disorder.
- It leads to excessive urinary oxalate and L-glycerate excretion.
- Complications range from mild to end-stage renal failure due to calcium oxalate crystal deposition.
Purpose of the Study:
- To review the clinical and biochemical aspects of PH2.
- To discuss the molecular basis of the disease, focusing on the GRHPR enzyme.
- To explore potential therapeutic strategies based on molecular insights.
Main Methods:
- Literature review of PH2.
- Identification of the glyoxylate reductase and hydroxypyruvate reductase (GRHPR) enzyme cDNA.
- Characterization of the human GRHPR gene and identification of patient mutations.
Main Results:
- The GRHPR enzyme is absent in PH2 patients.
- cDNA for GRHPR has been identified.
- Mutations in the GRHPR gene are associated with PH2.
Conclusions:
- PH2 is caused by defects in the GRHPR enzyme.
- Molecular understanding of PH2 aids in identifying mutations and potential therapies.
- Further research into GRHPR function and mutations is crucial for clinical management.